Products Liability
Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
Pending actions
3,928
Historical total
3,962
Resolved / remanded
34
Active. A substantial share of actions remain pending. Of 3,962 lawsuits ever part of this litigation, 3,928 remain active.
About this litigation
Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation is a federal multidistrict litigation classified by the Judicial Panel on Multidistrict Litigation as a Products Liability docket. It was centralized on February 2, 2024 before Karen S. Marston, U.S. District Judge, in the E.D. Pennsylvania.
As of the August 3, 2026 JPML report, 3,928 individual lawsuits are pending in this MDL. Cases coordinated in an MDL keep their separate identity — they are managed together only for pretrial proceedings. Learn how MDLs work.
Related Products Liability MDLs
View categoryJohnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
68,914
pending actions
MDL 2738
D. New Jersey
Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation
23,321
pending actions
MDL 2846
S.D. Ohio
Aqueous Film-Forming Foams Products Liability Litigation
15,246
pending actions
MDL 2873
D. South Carolina
Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation
11,779
pending actions
MDL 3060
N.D. Illinois